![Elaine Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elaine Jones
Director/Board Member at
NEXTCURE, INC.
Net worth: 345 957 $ as of 31/05/2026
Profile
Elaine V.
Jones is Chairman at BOOST Pharma ApS and Bionyra Pharma SAS since 2026.
Director at HBM Healthcare Investments AG since 2021.
Non-Executive Director at Autifony Therapeutics Ltd. Director at MISSION Therapeutics Ltd., Nimbus Apollo, Inc., STORM Therapeutics Ltd., Jnana Therapeutics, Inc., Atacama Resources International, Inc., and Ben Franklin Technology Partners.
Independent Director at CytomX Therapeutics, Inc. since 2019, NextCure, Inc. since 2015, Mironid Ltd. since 2019, and Novartis Venture since 2020.
Director at CREATE Medicines, Inc. (Massachusetts) since 2021.
Trustee at Juniata College since 2014.
Member of The Cancer Prevention & Research Institute of Texas since 2022.
Vice President at Pfizer Venture Investments LLC since 2007.
Former roles include Chairman at Nexoplex Bio, Inc. from 2020 to 2025.
Independent Director at Mersana Therapeutics, Inc. from 2015 to 2018, Flexion Therapeutics, Inc. from 2009 to 2014, Aquinox Pharmaceuticals, Inc. from 2010 to 2015, CytomX Therapeutics, Inc. from 2014 to 2016, Mirna Therapeutics, Inc. from 2012 to 2016, and Ibere Pharmaceuticals from 2021 to 2023.
Vice President at GSK Equity Investments Ltd. from 1999 to 2003.
General Partner at EuclidSR Partners from 2003 to 2008.
VP-Worldwide Business Development & Senior Partner at Pfizer Ventures LLC from 2008 to 2019.
Director roles at Nimbus Therapeutics LLC, GSK Plc, Targacept, Inc., Acurian, Inc., Merus NV, NeuroTherapeutics Pharma, Inc., GlaxoSmithKline LLC, Second Genome, Inc., eFFECTOR Therapeutics Operations, Inc., Quartet Medicine, Inc., Blade Therapeutics, Inc., Kymera Therapeutics, Inc., SmithKline Beecham Pharmaceuticals Co., and NuoDB, Inc.Education includes undergraduate degree from Juniata College and doctorate from the University of Pittsburgh School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2025 | 1,075 ( 0.02% ) | 327 446 $ | 31/05/2026 | |
| 17/06/2026 | 5,142 ( 0% ) | 18 511 $ | 31/05/2026 | |
NEXTCURE, INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Elaine Jones active positions
| Companies | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Director/Board Member | 01/12/2015 |
| CYTOMX THERAPEUTICS, INC. | Director/Board Member | 01/05/2019 |
| HBM HEALTHCARE INVESTMENTS AG | Director/Board Member | 18/06/2021 |
| ATACAMA RESOURCES INTERNATIONAL, INC. | Director/Board Member | - |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Director/Board Member | - |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Director/Board Member | - |
Mironid Ltd.
 Mironid Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary drug candidate molecules | Director/Board Member | 01/01/2019 |
Boostpharma ApS
 Boostpharma ApS BiotechnologyHealth Technology Develops a stem cell therapy for treatment of osteogenesis imperfecta | Chairman | 01/01/2026 |
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Director/Board Member | 31/03/2021 |
Former positions of Elaine Jones
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Elaine Jones
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
40
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 40 |
|---|---|
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
NuoDB, Inc.
 NuoDB, Inc. Packaged SoftwareTechnology Services Develops cloud-native distributed SQL database | Technology Services |
Atacama Resources International, Inc.
 Atacama Resources International, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in exploration of metal ores | Commercial Services |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
Juniata College
 Juniata College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Finance |
EuclidSR Partners
 EuclidSR Partners Investment ManagersFinance EuclidSR Partners seeks investment opportunities located in the US. The firm target companies operating in the fields of information technology, Convergence, Life sciences. The firm provides financing for early stage capital requirements. | Finance |
Acurian, Inc.
 Acurian, Inc. Medical/Nursing ServicesHealth Services Provides clinical trial patient recruitment and retention solutions for the life sciences industry | Health Services |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
NeuroTherapeutics Pharma, Inc.
 NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical and therapeutic drugs for central nervous system disorders | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
The Cancer Prevention & Research Institute of Texas
 The Cancer Prevention & Research Institute of Texas BiotechnologyHealth Technology Provides cancer research and prevention programs & services | Health Technology |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Health Technology |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quartet Medicine, Inc.
 Quartet Medicine, Inc. BiotechnologyHealth Technology Develops treatments for chronic pain and inflammation | Health Technology |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Mironid Ltd.
Mironid Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary drug candidate molecules | Health Technology |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Health Technology |
Pfizer Ventures LLC
 Pfizer Ventures LLC Financial ConglomeratesFinance Provides investment services | Finance |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
SmithKline Beecham Pharmaceuticals Co.
 SmithKline Beecham Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures drugs and vaccines | Health Technology |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
Boostpharma ApS
Boostpharma ApS BiotechnologyHealth Technology Develops a stem cell therapy for treatment of osteogenesis imperfecta | Health Technology |
Ibere Pharmaceuticals
 Ibere Pharmaceuticals Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Elaine Jones
Choose MarketScreener 
